Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications

LAUR Repository

Show simple item record

dc.contributor.author Ramia, Elsy
dc.contributor.author Zeenny, Rony
dc.date.accessioned 2017-12-19T11:41:18Z
dc.date.available 2017-12-19T11:41:18Z
dc.date.copyright 2014 en_US
dc.date.issued 2017-12-19
dc.identifier.uri http://hdl.handle.net/10725/6837
dc.description.abstract Purpose To evaluate the appropriateness of laboratory-test monitoring recommended for patients on chronic medication therapies in the Lebanese community setting. Patients and methods In October 2011, all outpatients visiting selected community pharmacies in Lebanon were screened by pharmacists to evaluate their use of one or more chronic medications requiring safety and/or therapeutic laboratory tests. The list of medications was elaborated after an extensive review of laboratory-test monitoring recommendations from pertinent up-to-date clinical guidelines, medications that have been issued black box warnings for monitoring, and the most current information from the US Food and Drug Administration website. Patients receiving these medications were subjected to a questionnaire assessing the appropriateness of their laboratory-test monitoring. The study was approved by the Lebanese American University’s Institutional Review Board. Results A total of 284 outpatients, with almost equal distribution by sex, were identified during the aforementioned period to be on one or more of the specified medications. The majority of the sample (68%) was younger than 65 years of age. Overall, most of the study group (65%) were found to be partially monitored with laboratory tests, while only 27% were fully monitored and 8% were not monitored at all. The study group reported clinic-visit intervals as follows: more than a year (35%), on yearly basis (18%), every 6 months (25%), every 3 months (16%), less than 3 months (6%). Conclusion Seventy-three percent (73%) of the study group were receiving incomplete therapeutic/safety laboratory-test monitoring recommended for patients on chronic medication in the Lebanese community. It is concluded from the results that patients need to better understand the importance of recommended test monitoring for the safe and effective use of their medications. Education by physicians may be required to achieve better understanding. en_US
dc.language.iso en en_US
dc.title Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications en_US
dc.type Article en_US
dc.description.version Published en_US
dc.title.subtitle a cross-sectional study en_US
dc.author.school SOP en_US
dc.author.idnumber 200302267 en_US
dc.author.department Pharmacy Practice en_US
dc.description.embargo N/A en_US
dc.relation.journal Patient Prefer Adherence en_US
dc.journal.volume 8 en_US
dc.article.pages 1195-1204 en_US
dc.keywords Chronic diseases
dc.keywords Diabetes
dc.keywords Disease management
dc.keywords Drugs
dc.keywords Hypertension
dc.keywords Laboratory tests
dc.keywords Primary care
dc.keywords Statins
dc.identifier.doi http://dx.doi.org/10.2147/PPA.S69250 en_US
dc.identifier.ctation Ramia, E., & Zeenny, R. (2014). Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study. Patient preference and adherence, 8, 1195-1204. en_US
dc.author.email elsy.ramia@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://pubmed.ncbi.nlm.nih.gov/25228798/ en_US
dc.orcid.id https://orcid.org/0000-0001-6447-4377
dc.author.affiliation Lebanese American University en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account